Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Search

Includes articles, courses, and CPGs. Unlimited access for APTA members.

Weighty Matters: Physical Therapy and GLP-1 Medications

Aug 1, 2025/Feature

What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.

Scrum and Recover: The PT Game Plan

Aug 1, 2025/Feature

Intense collisions, complex injuries, and no pads: Why physical therapy is essential to the sport of rugby — and what it teaches us about recovery.

Defining Moment | An Ounce of Prevention

Sep 1, 2025/Column

One PT’s longtime passion for helping older adults and preventive health combined into a promising career in falls prevention.

Advocacy Update | Requesting PTPAC Support for Political Fundraisers

Aug 1, 2025/Advocacy Update

Here’s how APTA members can request PTPAC disbursements to attend campaign events and ensure physical therapists have a seat at the table.

APTA President’s Note | Innovation in Action

Sep 1, 2025/Article

In this month’s column, APTA President Kyle Covington, PT, DPT, PhD, explores how innovation drives progress — and PTs and PTAs are leading the way.

Managing Patients Who Are Transgender

Jul 1, 2016/Feature

Patients who are transgender have certain unique needs. PTs are increasingly likely to work with this population. What do they need to know?

Raters Gonna Rate

Sep 1, 2015/Feature

What's Your Best Response?

Powering Progress in Primary Care

Apr 1, 2026/Article

How APTA and its members are working to advance physical therapists as entry-point providers.

An Insider's Guide to Getting the Most from Trade Shows

Aug 1, 2015/Feature

You can add surprising value to your time in a trade show exhibit hall once you discover why vendors are really there. And, no, selling you the latest version of their product often isn't at the top of the list.

Questioning the Path of Lease Resistance

Aug 1, 2015/Column

Think purchasing equipment always is the best option? Don't buy it.